Skip to main content
micro-community-banner
 
  • Saved

made a Post

Coronavirus Update: SK Bioscience, Biological E, DongWha And Celltrion Report Progress

SK Bioscience has received an IND approval from South Korea's Ministry of Food and Drug Safety (MFDS) to begin a Phase I clinical trial with its COVID-19 vaccine candidate NBP2001.The ..... see more

Source : 'Scrip Intelligence'

  • Saved

made a Post

Catchup Capsule: Key APAC Insights You Need To Read

 A selection of key stories from the Asia-based content team for the Pink Sheet and Scrip over the past few weeks reflects both the diversity of region and broader developments in the ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

COVID-19: Could Lateral Flow Test Using Glycan Recognition Be A Rapid Testing Breakthrough?

A low-cost, rapid test for SARS-CoV-2 that detects the virus’s interaction with sugars around cells, and may perform just as well if the virus mutates, is being tested in UK ..... see more

Source : Medtech Insight

  • Saved

made a Post

COVID-19: New Emergency Guidance From AAMI Targets Remote-Controlled Devices

The Association for the Advancement of Medical Instrumentation (AAMI) has released an emergency-use guidance that targets medical devices that can be used remotely during the coronavirus pandemic. ..... see more

Source : Medtech Insight

  • Saved

made a Post

COVID-19 Serology Templates: FDA Updates Sponsor Template, Adds Home Test Document

The US Food and Drug Administration has issued two new templates for developers to use in drafting emergency use authorization (EUA) requests for serology tests for COVID-19, reflecting the growing ..... see more

Source : Medtech Insight

  • Saved

made a Post

Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue

The US Food & Drug Administration needs to be more transparent about the details on the clinical holds that have been placed on COVID-19 vaccine candidates, including the reasons for ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Quick Listen: Scrip’s Five Must-Know Things

Join us in our regular podcast covering major industry events over the past week, in this audio version of Scrip's Five Must-Know Things, this time for the business week ended ..... see more

Source : 'Scrip Intelligence'

  • Saved

made a Post

Revlon Staves Off Bankruptcy, Reports Q3 With Notes Of Optimism

Revlon, Inc. has staved off bankruptcy with a hard-won exchange offer with investors, giving the company additional time to turn around its beleaguered business.According to its 13 November announcement, Revlon ..... see more

Source : 'HBW Insight'

  • Saved

made a Post

COVID-19 Vaccines: Can US FDA Complete Assessment In Less Than Six Weeks?

A 2020 emergency use authorization for a coronavirus vaccine still remains possible with interim data now available, but with less than two months left in the year, the pressure on ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Coronavirus Notebook: Moderna Claims 94.5% Vaccine Efficacy, Janssen Starts Second ENSEMBLE Trial

The big news of the week – and it’s only Monday – is that the US firm Moderna, Inc. is claiming an efficacy rate of 94.5% for its mRNA ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

EU Mandates Monthly Safety Summaries For Approved COVID-19 Vaccines

EU regulators have finalized additional safety reporting requirements for companies developing COVID-19 vaccines to support their ongoing monitoring in the post-authorization phase. The new requirements include submission of monthly summary ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Trump’s Big Bet On COVID-19 Vaccines May Have Shortchanged Therapeutics. Should Biden Rectify The Difference?

The US government has invested about four and a half times as much money in the development and manufacturing of potential COVID-19 vaccines to prevent the disease as it has ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Next Year’s Congress Likely To Reinforce ACA Preexisting Conditions, Attorneys Say

Industry attorneys are predicting that the new US Congress will work quickly to reestablish key provisions of the Affordable Care Act to assure the continuity of the ACA’s preexisting conditions, ..... see more

Source : Medtech Insight

  • Saved

from Pathologist Connect made a Post

How did breast cancer care change during COVID-19? How has the pandemic impacted cancer screening? What did I see as a pathologist? Tune in to find out. It’s FREE!

  • Saved

made a Post

Experts Skeptical As Russia’s COVID-19 Vaccine Outshines Pfizer Results

Russian scientists have claimed their COVID-19 vaccine candidate achieved a 92% efficacy rate in its first interim analysis of its Phase III trial, a remarkable result which suggests Sputnik V ..... see more

Source : 'Scrip Intelligence'